Kim JH - Search Results

1

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: kim iy, kim jh. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

2

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.

Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM, Lerner SP. Kim JH, et al. Among authors: kim iy. Cancer. 2001 Sep 15;92(6):1475-83. doi: 10.1002/1097-0142(20010915)92:6<1475::aid-cncr1472>3.0.co;2-x. Cancer. 2001. PMID: 11745225

3

Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.

Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C. Kim IY, et al. Among authors: kim jh. Cancer Res. 1996 Jan 1;56(1):44-8. Cancer Res. 1996. PMID: 8548772

4

Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.

Kim IY, Kim JH, Zelner DJ, Ahn HJ, Sensibar JA, Lee C. Kim IY, et al. Among authors: kim jh. Endocrinology. 1996 Mar;137(3):991-9. doi: 10.1210/endo.137.3.8603613. Endocrinology. 1996. PMID: 8603613

5

Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.

Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C. Kim IY, et al. Among authors: kim jh. Exp Cell Res. 1996 Jan 10;222(1):103-10. doi: 10.1006/excr.1996.0013. Exp Cell Res. 1996. PMID: 8549651

6

Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.

Kim JH, Sherwood ER, Sutkowski DM, Lee C, Kozlowski JM. Kim JH, et al. J Urol. 1991 Jul;146(1):171-6. doi: 10.1016/s0022-5347(17)37747-9. J Urol. 1991. PMID: 2056586

7

p53 Codon 72 Polymorphism and Cervical Adenocarcinoma Risk in Korean Women.

Kim JH, Roh JW, Kim KS, Jung HJ, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Kim JH, et al. Among authors: kim ks, kim jw. Cancer Res Treat. 2001 Jun;33(3):243-9. doi: 10.4143/crt.2001.33.3.243. Cancer Res Treat. 2001. PMID: 26680792

8

Cerebellar tDCS Enhances Functional Communication Skills in Chronic Aphasia.

Kim JH, Cust S, Lammers B, Sheppard SM, Keator LM, Tippett DC, Hillis AE, Sebastian R. Kim JH, et al. Aphasiology. 2024;38(12):1895-1915. doi: 10.1080/02687038.2024.2328874. Epub 2024 Mar 14. Aphasiology. 2024. PMID: 39555327 Free PMC article.

9

Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis.

Kim B, Lee SH, Ahn CH, Jang HN, Cho SI, Lee JS, Lee YM, Kim SJ, Sung TY, Lee KE, Lee W, Koh JM, Seong MW, Kim JH. Kim B, et al. Among authors: kim jh. Endocrinol Metab (Seoul). 2024 Nov 18. doi: 10.3803/EnM.2024.2008. Online ahead of print. Endocrinol Metab (Seoul). 2024. PMID: 39552147

10

Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.

Shin KI, Yoon MS, Kim JH, Jang WJ, Leem G, Jo JH, Chung MJ, Park JY, Park SW, Hwang HK, Kang CM, Kim SS, Park MS, Lee HS, Bang S. Shin KI, et al. Among authors: kim jh. Cancer Med. 2024 Nov;13(22):e70363. doi: 10.1002/cam4.70363. Cancer Med. 2024. PMID: 39552022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,043 results

Search Page

Filters